Oaktree Acquisition Corp. III Life Sciences

NASDAQ:OACC

Shell Companies

Financial Services
$10.72 +0.00%

+$0.00 today

Market cap
$263.53M
Beta
-0.04
P/E (TTM)
29.1
EPS (TTM)
$0.37
52W Low $10.30High $10.74

Volume 0.00M

Average 0.01M

OACC Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Oaktree Acquisition Corp. III Life SciencesNASDAQ: OACC

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents broadly unchanged from a year ago

Cash & equivalents stood at $1.28M at the end of Q1 FY2026, down 0.4% from a year earlier and down 11.0% from the prior quarter.

Context

  • Cash & equivalents amounted to 0.6% of total assets at the end of Q1 FY2026, unchanged from a year earlier.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -0.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.28M-11.0% QoQ
Last fiscal yearDec 2025
$1.43M+5.7% YoY
Year agoMar 2025
$1.28M-0.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.4%——
1 year+5.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
1.43M USD
Year-over-year change
+5.7%
1-year CAGR
+5.7%

Cash & Equivalents vs competitors

How OACC compares with its peers on the latest reported figures

  • OACC's Mar 2026 cash & equivalents of $1.28M is the highest of the 10 companies compared; the peer median is $155.43K.
  • Its year-over-year change of -0.4% is the 3rd highest of 7, against a peer median of -75.6%.
  • Cash & equivalents amounts to 0.6% of total assets for OACC, versus a peer median of 0.1%.
OACC Competitors Peer median
Cash & Equivalents for OACC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OACCOaktree Acquisition Corp. III Life SciencesMar 2026$1.28M -0.4%—0.6%
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary sharesMar 2026$876.08K +7.0%—0.3%
PMTRPerimeter Acquisition Corp. I Class A Ordinary SharesMar 2026$503.43K ——0.2%
FACTFACT II Acquisition CorpMar 2026$412.91K -66.2%+95.5%0.2%
CGCTCartesian Growth Corporation IIIMar 2026$396.21K ——0.1%
RACRithm Acquisition Corp.Mar 2026$155.43K -85.0%—0.1%
MLACMountain Lake Acquisition Corp.Mar 2026$66.57K -94.5%+136.4%0.0%
SOULSoulpower Acquisition Corp.Mar 2026$56.4K +1616.5%—0.0%
AACBArtius II Acquisition Inc. Class A Ordinary SharesMar 2026$20.3K -94.3%—0.0%
COPLCopley Acquisition CorpMar 2026$4.24K ——0.0%
Peer median (excluding OACC) $155.43K-75.6%+115.9%0.1%

Competitors are the stored peer set for OACC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Oaktree Acquisition Corp. III Life Sciences

NASDAQ:OACC

Intrinsic Alpha fair value

Locked

Current Price

$10.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.